Cited by 151Histone Deacetylase Inhibitors ResearchEpigenetics and DNA MethylationGenomics and Chromatin Dynamics

Histone deacetylases (HDACs) and brain function

Open access
Volmar, Claude-Henry, Wahlestedt, Claes·2015·Neuroepigenetics

Abstract

Modulation of gene expression is a constant and necessary event for mammalian brain function. An important way of regulating gene expression is through the remodeling of chromatin, the complex of DNA, and histone proteins around which DNA wraps. The “histone code hypothesis” places histone post-translational modifications as a significant part of chromatin remodeling to regulate transcriptional activity. Acetylation of histones by histone acetyl transferases and deacetylation by histone deacetylases (HDACs) at lysine residues are the most studied histone post-translational modifications in cognition and neuropsychiatric diseases. Here, we review the literature regarding the role of HDACs in brain function. Among the roles of HDACs in the brain, studies show that they participate in glial lineage development, learning and memory, neuropsychiatric diseases, and even rare neurologic diseases. Most HDACs can be targeted with small molecules. However, additional brain-penetrant specific inhibitors with high central nervous system exposure are needed to determine the cause-and-effect relationship between individual HDACs and brain-associated diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.nepig.2014.10.002

Cites

109 of 109 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Interference in nonneuronal or inappropriate neuronal locations may induce side effects and off-target effects.

    “Interference in nonneuronal or inappropriate neuronal locations may induce side effects and off-target effects.409”

    From Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential (2023) · cites this paper as [409]

    The Concluding remarks (page not provided) report substantial side effects in clinical trials and suggest that insufficient drug specificity or excessive dosing may explain them. The paper also says current HDAC inhibitors often affect multiple HDACs, but it does not specifically attribute side effects to interference in nonneuronal or inappropriate neuronal locations. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • HDACs have been implicated in a range of neuropsychiatric disorders, including depression and schizophrenia, and HDAC inhibitors could be potential cognitive enhancers in anxiety- and fear-related disorders.

    “HDACs have been implicated in a range of neuropsychiatric disorders [e.g., depression and schizophrenia (358)] and HDAC inhibitors could be potential cognitive enhancers in anxiety-and fear-related disorders (359).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Volmar, C.-H., & Wahlestedt, C.
Affiliations
University of Miami (US)
Corresponding author
Volmar, Claude-Henry
Venue
Neuroepigenetics
Publisher
Elsevier BV
Published
2015-01
Volume
1
Pages
20-27
ISSN
2214-7845 (ISSN-L)
OpenAlex
W1970192287
Cited by
151
References
109
Citations by year
2026: 7 · 2025: 8 · 2024: 6 · 2023: 14 · 2022: 11 · 2021: 13 · 2020: 18 · 2019: 12 · 2018: 23 · 2017: 19 · 2016: 15 · 2015: 5
FWCI
5.33
Type
journal article
Language
en
Open access
Locations
Neuroepigenetics (publishedVersion, cc-by-nc-nd)
Funders
  • University of Miami
  • Pfizer’s Centers for Therapeutic Innovation
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords
histone deacetylase, brain function, chromatin remodeling, histone modifications, histone acetylation, histone acetyltransferase, gene expression regulation, learning and memory, neuropsychiatric disorders, neurological disorders, histone deacetylase inhibitors, brain-penetrant drugs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review